These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 39038048)

  • 1. APOER2 splicing repertoire in Alzheimer's disease: Insights from long-read RNA sequencing.
    Gallo CM; Kistler SA; Natrakul A; Labadorf AT; Beffert U; Ho A
    PLoS Genet; 2024 Jul; 20(7):e1011348. PubMed ID: 39038048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased generation of C-terminal fragments of ApoER2 and increased reelin expression in Alzheimer's disease.
    Mata-Balaguer T; Cuchillo-Ibañez I; Calero M; Ferrer I; Sáez-Valero J
    FASEB J; 2018 Jul; 32(7):3536-3546. PubMed ID: 29442527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human APOER2 Isoforms Have Differential Cleavage Events and Synaptic Properties.
    Omuro KC; Gallo CM; Scrandis L; Ho A; Beffert U
    J Neurosci; 2022 May; 42(20):4054-4068. PubMed ID: 35414534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic correction of ApoER2 splicing in Alzheimer's disease mice using antisense oligonucleotides.
    Hinrich AJ; Jodelka FM; Chang JL; Brutman D; Bruno AM; Briggs CA; James BD; Stutzmann GE; Bennett DA; Miller SA; Rigo F; Marr RA; Hastings ML
    EMBO Mol Med; 2016 Apr; 8(4):328-45. PubMed ID: 26902204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the hippocampal translatome by Apoer2-ICD release.
    Wasser CR; Werthmann GC; Hall EM; Kuhbandner K; Wong CH; Durakoglugil MS; Herz J
    Mol Neurodegener; 2023 Sep; 18(1):62. PubMed ID: 37726747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid Peroxidation Induced ApoE Receptor-Ligand Disruption as a Unifying Hypothesis Underlying Sporadic Alzheimer's Disease in Humans.
    Ramsden CE; Keyes GS; Calzada E; Horowitz MS; Zamora D; Jahanipour J; Sedlock A; Indig FE; Moaddel R; Kapogiannis D; Maric D
    J Alzheimers Dis; 2022; 87(3):1251-1290. PubMed ID: 35466940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The β-amyloid peptide compromises Reelin signaling in Alzheimer's disease.
    Cuchillo-Ibañez I; Mata-Balaguer T; Balmaceda V; Arranz JJ; Nimpf J; Sáez-Valero J
    Sci Rep; 2016 Aug; 6():31646. PubMed ID: 27531658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single molecule, long-read Apoer2 sequencing identifies conserved and species-specific splicing patterns.
    Gallo CM; Labadorf AT; Ho A; Beffert U
    Genomics; 2022 Mar; 114(2):110318. PubMed ID: 35192893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurexin 3 transmembrane and soluble isoform expression and splicing haplotype are associated with neuron inflammasome and Alzheimer's disease.
    Hishimoto A; Pletnikova O; Lang DL; Troncoso JC; Egan JM; Liu QR
    Alzheimers Res Ther; 2019 Mar; 11(1):28. PubMed ID: 30902061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of synaptic plasticity and memory by Reelin involves differential splicing of the lipoprotein receptor Apoer2.
    Beffert U; Weeber EJ; Durudas A; Qiu S; Masiulis I; Sweatt JD; Li WP; Adelmann G; Frotscher M; Hammer RE; Herz J
    Neuron; 2005 Aug; 47(4):567-79. PubMed ID: 16102539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF-ApoER2 fragments as a read-out of reelin signaling: Distinct patterns in sporadic and autosomal-dominant Alzheimer disease.
    Lopez-Font I; Iborra-Lazaro G; Sánchez-Valle R; Molinuevo JL; Cuchillo-Ibañez I; Sáez-Valero J
    Clin Chim Acta; 2019 Mar; 490():6-11. PubMed ID: 30552869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The apolipoprotein receptor LRP3 compromises APP levels.
    Cuchillo-Ibañez I; Lennol MP; Escamilla S; Mata-Balaguer T; Valverde-Vozmediano L; Lopez-Font I; Ferrer I; Sáez-Valero J
    Alzheimers Res Ther; 2021 Nov; 13(1):181. PubMed ID: 34727970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Reelin Receptors Apolipoprotein E receptor 2 (ApoER2) and VLDL Receptor.
    Dlugosz P; Nimpf J
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30304853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of exon skipping events associated with Alzheimer's disease in the human hippocampus.
    Han S; Miller JE; Byun S; Kim D; Risacher SL; Saykin AJ; Lee Y; Nho K;
    BMC Med Genomics; 2019 Jan; 12(Suppl 1):13. PubMed ID: 30704480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ApoER2 processing by presenilin-1 modulates reelin expression.
    Balmaceda V; Cuchillo-Ibáñez I; Pujadas L; García-Ayllón MS; Saura CA; Nimpf J; Soriano E; Sáez-Valero J
    FASEB J; 2014 Apr; 28(4):1543-54. PubMed ID: 24344333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoer2-ICD-dependent regulation of hippocampal ribosome mRNA loading.
    Wasser C; Werthmann GC; Hall EM; Kuhbandner K; Wong CH; Durakoglugil MS; Herz J
    Res Sq; 2023 Jun; ():. PubMed ID: 37461529
    [No Abstract]   [Full Text] [Related]  

  • 17. Splicing variations in the ligand-binding domain of ApoER2 results in functional differences in the binding properties to Reelin.
    Hibi T; Mizutani M; Baba A; Hattori M
    Neurosci Res; 2009 Apr; 63(4):251-8. PubMed ID: 19167437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning.
    Weeber EJ; Beffert U; Jones C; Christian JM; Forster E; Sweatt JD; Herz J
    J Biol Chem; 2002 Oct; 277(42):39944-52. PubMed ID: 12167620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole transcriptome sequencing reveals gene expression and splicing differences in brain regions affected by Alzheimer's disease.
    Twine NA; Janitz K; Wilkins MR; Janitz M
    PLoS One; 2011 Jan; 6(1):e16266. PubMed ID: 21283692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ApoER2: Functional Tuning Through Splicing.
    Gallo CM; Ho A; Beffert U
    Front Mol Neurosci; 2020; 13():144. PubMed ID: 32848602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.